Furthermore, we found that RRM2 depletion mitigated the alterations in the IC50 values of sunitinib induced by either the overexpression or knockdown of IKBKE in renal cancer cells (Figure 6I-J). The gene discussed is RRM2; the disease is renal carcinoma.